Drug Shortage Report for NUCYNTA EXTENDED-RELEASE

Last updated on 2017-12-06 History
Report ID 25129
Drug Identification Number 02415593
Brand name NUCYNTA EXTENDED-RELEASE
Common or Proper name Nucynta
Company Name ENDO VENTURES LTD.
Market Status MARKETED
Active Ingredient(s) Tapentadol
Strength(s) 150MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 60 Tabs
ATC code N02AX
ATC description OPIOIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-12-30
Actual start date
Estimated end date 2017-12-06
Actual end date 2017-12-06
Shortage status Avoided shortage
Updated date 2017-12-06
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD
BALLSBRIDGE, DUBLIN
IRELAND D04 H9P8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2017-12-06 French Compare
v3 2017-12-06 English Compare
v2 2017-10-10 French Compare
v1 2017-10-10 English Compare

Showing 1 to 4 of 4